IP Library Granted Patent US 8,545,896
Granted Patent B2
US 8,545,896 · App. 13/459,616 · Granted Oct 1, 2013

Compositions, kits and methods for nutrition supplementation

Inventors: Philippe Perrin (Paris, FR); Guillaume Herry (Hoboken, NJ); Cecile Boyer-Joubert (Fontenay aux Roses, FR)
Assignee: Chemo S. A. France
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,545,896
App. No.
13/459,616
Granted
Oct 1, 2013
Kind
B2
Abstract

The present invention relates to compositions, kits and methods for the administration of various vitamin, mineral and nutrient compositions, and in a specific embodiment, the compositions, kits and methods may utilize or include twelve carbon chain fatty acids and/or twelve carbon chain acylglycerols, vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega 3 fatty acids and one or more pharmaceutically acceptable carriers.

Claims (21)

1. A composition consisting of: a twelve carbon chain fatty acid or twelve carbon chain acylglycerol; and vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega 3 fatty acids and one or more pharmaceutically acceptable carriers; wherein said composition is for nutritional supplementation in a patient.

2. The composition of claim 1 , wherein said omega 3 fatty acids is in the form selected from one or more of the group consisting docosahexaenoic acid, (DHA), eicosapentaenoic acid (EPA) and α-linolenic acid (ALA).

3. The composition of claim 1 , wherein said iodine is present in an amount of about 100 μg to about 300 μg.

4. The composition of claim 1 , wherein said iodine is present in an amount of about 200 μg.

5. The composition of claim 1 , wherein said omega 3 fatty acids comprises DHA.

6. The composition of claim 5 , wherein said DHA is present in an amount of about 100 mg to about 300 mg.

7. The composition of claim 5 , wherein said DHA is present in an amount of about 200 mg.

8. The composition of claim 5 , wherein the source of said DHA comprises one or more of the group consisting of animal, fish, plants, algae or microorganism production.

9. The composition of claim 8 , wherein the source of DHA is algae oil and/or fish oil.

10. The composition of claim 1 , wherein said twelve carbon chain fatty acid or twelve carbon chain acylglycerol comprises one or more of the group consisting of lauric acid, glycerol monolaurate (monolaurin), dilaurin, trilaurin, a twelve carbon chain monoacylglycerol, a twelve carbon chain unsaturated fatty acid, a diacylglycerol comprising at least one twelve carbon chain and a triacylglyceral comprising at least one twelve carbon chain.

11. The composition of claim 10 , wherein said twelve carbon chain fatty acid or twelve carbon chain acylglycerol comprises lauric acid.

12. The composition of claim 11 , wherein said lauric acid is derived from a natural or synthetic source or is genetically engineered.

13. The composition of claim 11 , wherein the source of said lauric acid is from one or more of the group consisting of algae oil, Martek Algae oil, coconut oil, babassu oil, and palm kernel oil.

14. The composition of claim 1 , wherein said twelve carbon chain fatty acid or twelve carbon chain acylglycerol is present in an amount of about 30 mg to about 300 mg.

15. The composition of claim 1 , wherein said twelve carbon chain fatty acid or twelve carbon chain acylglycerol is derived from one or more selected from the group consisting of coconut oil and algae oil and is present in a total amount of about 30 mg to about 300 mg.

16. The composition of claim 1 , wherein said twelve carbon chain fatty acid or twelve carbon chain acylglycerol is lauric acid derived from one or more selected from the group consisting of coconut oil and algae oil and is present in a total amount of about 60 mg.

17. The composition of claim 1 , wherein said vitamin D is present in an amount of about 500 I.U. to about 1500 I.U., said twelve carbon chain fatty acid or twelve carbon chain acylglycerol is present in an amount of about 30 mg to about 300 mg, said iodine is present in an amount of about 100 μg to about 300 μg, said vitamin B1 is present in an amount of about 0.8 mg to about 2.4 mg, said vitamin B6 is present in an amount of about 1.2 mg to about 3.8 mg, said vitamin B12 is present in an amount of about 6 μg to about 18 μg, said vitamin B2 is present in an amount of about 0.9 mg to about 2.7 mg, said vitamin B9 is present in an amount of about 0.5 mg to about 1.5 mg, said vitamin E is present in an amount of about 5 I.U. to about 15 I.U., said vitamin A is present in an amount of about 550 I.U. to about 1650 I.U., said vitamin C is present in an amount of about 6 mg to about 18 mg, said vitamin B3 is present in an amount of about 7.5 mg to about 22.5 mg, said iron is present in an amount of about 13.5 mg to about 40.5 mg, said zinc is present in an amount of about 7.5 mg to about 22.5 mg, said copper is present in an amount of about 1.0 mg to about 3.0 mg, said magnesium is present in an amount of about 2.5 mg to about 7.5 mg, and said omega 3 fatty acids is present in an amount of about 100 mg to about 300 mg.

18. The composition of claim 1 , wherein said composition is provided in the dosage form of a gelcap.

19. The composition of claim 1 , wherein said composition is a dietary supplement or a prescription prenatal vitamin.

20. The composition of claim 1 , wherein said vitamin B9 comprises 5-methyl-(6S)-tetrahydrofolic acid or a salt thereof.

21. The composition of claim 20 , wherein said salt is a calcium salt.

Assignments (2)
CHANGE OF NAME Recorded Dec 10, 2019
From: CHEMO S.A. FRANCE
To: EXELTIS FRANCE
Reel/Frame 051239/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2015
From: PERRIN, PHILIPPE; HERRY, GUILLAUME; BOYER-JOUBERT, CECILE
To: CHEMO S.A. FRANCE
Reel/Frame 037374/0647 →
Continuity (2)
Continuation 13248428 · Sep 29, 2011
Related Publication 20130084344A1 · Apr 4, 2013